| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |